AdvaStim’s CTO Barry Yomtov to Present at The Neurotech Investing & Partnering Conference 2014 in Boston on April 23
Barry Yomtov, CTO of AdvaStim, will be a presenter at The Neurotech Investing & Partnering Conference 2014 on Wednesday, April 23. Now in its 9th year, The Neurotech Conference is a two-day global forum where investors, executives, entrepreneurs, scientists, and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry.
CrowdComfort Is Finalist in Business Plan Competition Sponsored by Salem State University’s Enterprise Center
NSIV is pleased to announce that one of its members, CrowdComfort, has been selected as a finalist in Salem State University’s Enterprise Center “2014 Business Plan Competition.” CrowdComfort and two other finalists will have an opportunity to present their business plans before a live panel of judges and compete for first, second, and third place on Wednesday, April 23, from 3 to 6 pm. (the location TBA). First place winner will receive $5,000; second place winner, $3,000; third place winner, $2,000. For details on the 2014 Business Plan competition, go to www.enterprisectr.org. CrowdComfort is a mobile solution for the modern facility manager. It’s easy-to-use smart phone application lets building owners, operators, and occupants share information about building comfort, maintenance, and safety issues. CrowdComfort streamlines three distinct areas of need, and leverages employee feedback (by means of the app) to report real-time conditions of buildings and facilities. Whether reporting about thermal levels, environmental compliance and inspection issues, or facilities maintenance, the CrowdComfort app uses crowd source feedback as a way of collecting the most up-to-the-minute and accurate reports that benefit employees, owners, and building managers alike! Go CrowdComfort!
The issuing of AdvaStim’s Wireless Remote Stimulator patent is an important milestone for AdvaStim. According to CTO Barry Yomtov, “The IP within this patent could be considered a home run because of its potential impact to the implantable neurostimulation device industry.” Don Freeman, NSIV board member and AdvaStim advisor, notes, “There’s a huge difference between “a filing” and “an issued” patent. I’m sure that difference will be recognized. Very well done, Barry.” For more information on AdvaStim, visit www.advastim.com.
Contacts: Martha Farmer, Ph.D. President & CEO North Shore InnoVentures 508-527-1832 Click here to start an email Media: Paul Sagan KCSA Strategic Communications 617-852-0495 Click here to start an email North Shore InnoVentures Receives $1.65 Million from the Massachusetts Life Sciences Center Award is part of $5 million grant to Colleges and Incubators to fund Lab/Facility and Equipment Upgrades in North Shore region BEVERLY, MA, March 28, 2014. North Shore InnoVentures, (NSIV) one of New England’s leading technology incubators and business accelerators, announced today that it has received a capital grant of $1.65 million from the Massachusetts Life Sciences Center (MLSC). The grant will allow NSIV to expand its current laboratory facilities over the next three years and purchase advanced analytical instrumentation. This grant is part of a larger $5 million award to the Life Sciences Consortium of the North Shore (LSCNS), consisting of Endicott College, Gordon College,North Shore InnoVentures, North Shore Community College and Salem State University, and will fund major lab/facility and equipment upgrade projects at the member institutions and organizations.
When Endicott College was conceptualizing a new science center in 2012, the college made a critical decision to build a facility that would exploit one of the fastest growing sectors in Massachusetts, particularly on the North Shore – the life sciences. To that end, the college built a 2,000 square-foot laboratory that would accommodate between one and three startup companies as a STEM incubator. In September 2013, The Ginger Judge Science Center opened its doors.
The World’s First Crowdsourced Thermostat Lets You Adjust The Temperature At Work By Ben Schiller People in a building know when they are hot or cold. This device simply asks them, and then adjusts the temperature accordingly.
NSIV is pleased to announce that Marc Bazin, founder and president of HepatoChem, Inc., has joined the advisory board of the Life Sciences Consortium of North Shore. In this role, Marc provides an entrepreneurial perspective on the many facets of being a biotech startup.
Congratulations to NSIV graduate 7AC Technologies for raising $1 million in venture financing from 31 investors. Founded in 2009, 7AC develops a highly disruptive membrane-isolated plastic plate technology for use in commercial and industrial liquid desiccant HVAC applications and in air conditioning and cooling. Reportedly, the new technology drastically cuts energy costs for heating and cooling, and radically improves de-humidification performance. For more information, go to www.7AC Technologies.
Tom Kinneman has proven (again) what he’s made of…100% iron. On Sunday, November 3, Tom won first place at Ironman Florida in his age group of 64 triathletes, finishing in 10:40:27 (impressive stats: 1:12 for the swim; 5:28 on the bike; 3:46 for the run).
What an extraordinary achievement…Quad Technologies has been nominated as one of the top 26 finalists in the MassChallenge 2013. Imagine making the final cut in a global competition in which 128 finalists were selected out of a pool of more than 1,200 candidates. NSIV is so proud to have Quad Technologies as a biotech member.